O'Day Daniel Patrick's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Jun 2, 2025
- Accession no.
- 0001127602-25-016281
- Filed
- Jun 2, 2025
- Trade date
- May 30, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.10M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Day Daniel PatrickCIK 0001638643 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | SSaleDisposed | −6,416 | $110.11 | −$706,465.76 | 623,852 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −3,584 | $110.96 | −$397,680.64 | 620,268 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.